Suchergebnisse - "Laharie, David"

PubPharm (290)

21

Comparative Effectiveness of Ustekinumab and Anti-TNF Agent as First-Line Biological Therapy in Luminal Crohn's Disease : A Retrospective Study From 2 Referral Centers

enthalten in: Inflammatory bowel diseases | 2023

von Rivière, P. | Kanters, C. | Pellet, G. | +10

22

A Rare Cause of Colonic Obstruction in Inflammatory Bowel Disease

enthalten in: The American journal of gastroenterology | 2023

von Le Cosquer, G. | Célérier, B. | Laharie, D.

23

Efficacy of Induction Therapy With Calcineurin Inhibitors in Combination With Ustekinumab for Acute Severe Ulcerative Colitis

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2023

von Veyrard, P. | Pellet, G. | Laharie, D. | +3

24

Preoperative Predictors of Neoplasia in Patients Undergoing Small Bowel Resection for Complicated Crohn's Disease : A Multicentre Case-Control Study

enthalten in: Cancers | 2023

von Chappe, C. | Salut, C. | Amiot, A. | +16

25

Distinct blood protein profiles associated with the risk of short-term and mid/long-term clinical relapse in patients with Crohn's disease stopping infliximab : when the remission state hides different types of residual disease activity

enthalten in: Gut | 2023

von Pierre, N. | Huynh-Thu, V. | Marichal, T. | +8

26

Comparison of the Risk of Crohn's Disease Postoperative Recurrence Between Modified Rutgeerts Score i2a and i2b Categories : An Individual Patient Data Meta-analysis

enthalten in: Journal of Crohn's & colitis | 2023

von Rivière, P. | Pekow, J. | Hammoudi, N. | +15

27

I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2023

von Peyrin-Biroulet, L. | Rahier, J. | Kirchgesner, J. | +120

28

Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease : a case-control study

enthalten in: Infection prevention in practice | 2023

von Amiot, A. | Bourrier, A. | Gornet, J. | +16

29

Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE) : a multicentre, open-label, randomised controlled trial

enthalten in: The lancet. Gastroenterology & hepatology | 2023

von Louis, E. | Resche-Rigon, M. | Laharie, D. | +49

CommentIn: Lancet Gastroenterol Hepatol. 2023 Mar;8(3):200-201. - PMID 36640793

30

Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease : A GETAID multicentre cohort study

enthalten in: Alimentary pharmacology & therapeutics | 2023

von Fumery, M. | Defrance, A. | Roblin, X. | +22

CommentIn: Aliment Pharmacol Ther. 2023 Apr;57(8):909-910. - PMID 36952268